Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
… Due to therapeutic failure with rituximab, she was switched to anifrolumab. Twelve days after the first infusion, she developed a painful …
… a saline suppression test in 2025 confirmed PA. Treatment with spironolactone (25mg daily, later increased to 37.5mg) is ongoing, with partia…
…tologic (lymphopenia), and serologic activity (SLEDAI-2K 6–8 on prednisolone 10 mg/day).Results In August 2024, anifrolumab 300 mg IV monthl…
…treatments included glucocorticoids (72.4%), immunosuppressants—methotrexate, azathioprine, or mycophenolate—(46%) and antimalarials (82.7%)…
…, ANI was administered concomitantly with antimalarials (n=16), mycophenolate mofetil (n=11), tacrolimus (n=4), azathioprine (n=2), methotrexate (n=1…
…3), organ damage (SLICC/ACR Damage Index) (SDI), treatments and prednisone dosages for every visit were collected.We compared patients nev…
…ntation in 2014, he was on hydroxychloroquine, methotrexate and coumadin with a therapeutic INR. His testicular Doppler ultrasound was s…
…A 1:1280, anti-dsDNA positive, low C3/C4). Initial therapy with hydroxychloroquine (200 mg/day) and low-dose prednisone (7.5 mg/day) achieved clin…
…ive analysis of 210 SLE patients treated between 2000-2022 with rituximab. Super-responders were defined by: (1) at least 3 years of foll…
…prine (16%), methotrexate (9%), and mycophenolate mofetil (9%). Rituximab was used in 7% of severe or treatment-resistant patients.Conclu…
…itive association between PJP and these csDMARDs: azathioprine, leflunomide, mycophenolate, and cyclosporin. In causal model for each of cs…
…es (PROs) in patients with rheumatoid arthritis (RA) initiating tofacitinib in a real-world setting.Design The non-interventional study ESC…